Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation

Gilles Lemesle

Université de Lille, Institut Pasteur de Lille, INSERM Unité 1011, Lille, France

Romain Didier

Cardiology Department, CHU Brest, Brest, France

Philippe Gabriel Steg

French Alliance for Cardiovascular Trials, Paris

Tabassome Simon

French Alliance for Cardiovascular Trials, Paris

Gilles Montalescot

Sorbonne Université, Paris

Nicolas Danchin

French Alliance for Cardiovascular Trials, Paris

Christophe Bauters

Heart and Lung Institute, University Hospital of Lille, Centre Hospitalier Universitaire (CHU) Lille, Lille, France

Didier Blanchard

Department of Cardiology, AP-HP, Hôpital Européen Georges Pompidou, Paris

Claire Bouleti

University of Poitiers, Clinical Investigation Center, INSERM 1402, Poitiers, France

Denis Angoulvant

Stéphane Andrieu

Department of Cardiology, Hôpital Henri-Duffaut, Avignon, France

Gérald Vanzetto

Department of Cardiology, Grenoble University Hospital, La Tronche, France

Mathieu Kerneis

AP-HP, Hôpital Pitié–Salpêtrière, Paris

Véronique Decalf

Department of Cardiology and Cardiovascular Diseases, Hôpital NOVO, Pontoise, France

Etienne Puymirat

Université Paris-Cité, Paris

Dominique Mottier

INSERM Unité Mixte de Recherche (UMR) 1304–Groupe d’Études Tumeurs et Biothérapies Oncologiques (GETBO) Brest, France

Abdourahmane Diallo

Unité de Recherche Clinique de l’Est Parisien (URCEST), Paris

Eric Vicaut

Unité de Recherche Clinique de l’Est Parisien (URCEST), Paris

Martine Gilard

Cardiology Department, CHU Brest, Brest, France

Guillaume Cayla

Cardiology Department, Nimes University Hospital, Montpellier University, ACTION Study Group, Nimes, France